Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bone.
What is Multiple Myeloma?

Multiple myeloma is a form of cancer that affects the bone marrow. The cancer is also called Kahler’s disease, named after an Austrian pathologist called Otto Kahler who first described the condition.

Read More

Overview

Feature Articles

Latest Multiple Myeloma News and Research

Scientists illuminate how blood cancer treatments can lead to therapy-related myeloid neoplasms

Scientists illuminate how blood cancer treatments can lead to therapy-related myeloid neoplasms

Study elucidates the potential role of STRO-001 in B-cell non-Hodgkin lymphoma

Study elucidates the potential role of STRO-001 in B-cell non-Hodgkin lymphoma

Cedars-Sinai's Stem Cell and Bone Marrow Transplant Program recognized with two major hallmarks of quality

Cedars-Sinai's Stem Cell and Bone Marrow Transplant Program recognized with two major hallmarks of quality

Simple method increases the efficacy of T cell therapy by cytokine conjugation

Simple method increases the efficacy of T cell therapy by cytokine conjugation

COVID-19 vaccination protects people with B cell lymphoma and multiple myeloma

COVID-19 vaccination protects people with B cell lymphoma and multiple myeloma

Experts provide first framework for treating hypercalcemia of malignancy in adults

Experts provide first framework for treating hypercalcemia of malignancy in adults

Enzyme inhibition reduces cancer-related bone loss and the number of bone metastases

Enzyme inhibition reduces cancer-related bone loss and the number of bone metastases

Novel drug shows early potential in combating multiple myeloma

Novel drug shows early potential in combating multiple myeloma

Off-the-shelf immunotherapy could offer new hope for patients with hard-to-treat multiple myeloma

Off-the-shelf immunotherapy could offer new hope for patients with hard-to-treat multiple myeloma

The critical role of flow cytometry in CAR+ T-Cell trials

The critical role of flow cytometry in CAR+ T-Cell trials

Novel molecular imaging radiotracer can precisely diagnose multiple cancers

Novel molecular imaging radiotracer can precisely diagnose multiple cancers

Researchers are developing calculator that weighs risk and benefit of taking osteoporosis drugs

Researchers are developing calculator that weighs risk and benefit of taking osteoporosis drugs

Researchers make first bone marrow 'organoids' to capture key features of human bone marrow

Researchers make first bone marrow 'organoids' to capture key features of human bone marrow

Researchers identify therapies for multiple myeloma patients whose cancer relapses after CAR-T

Researchers identify therapies for multiple myeloma patients whose cancer relapses after CAR-T

Mayo Clinic scientists awarded $12.1 million NCI grant for breast cancer research

Mayo Clinic scientists awarded $12.1 million NCI grant for breast cancer research

CAR T-cell therapy produces impressive results in first clinical trial in patients with multiple myeloma

CAR T-cell therapy produces impressive results in first clinical trial in patients with multiple myeloma

Houston Methodist researchers receive CPRIT funding to research two of the most lethal cancers

Houston Methodist researchers receive CPRIT funding to research two of the most lethal cancers

New CT technology paired with deep learning denoising enables better detection of multiple myeloma bone disease

New CT technology paired with deep learning denoising enables better detection of multiple myeloma bone disease

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

New approach using CRISPR can engineer massive quantities of cells for therapeutic applications

New approach using CRISPR can engineer massive quantities of cells for therapeutic applications